Stimulant drugs for hyperactivity: some additional disturbing questions.
Continued professional recognition and concern are urged in regard to increased use of stimulant drugs for treatment of hyperactivity, unaccompanied by 1) adequate interdisciplinary communication about specific behaviors leading to referral and treatment, or 2) adequate assessment of the behavioral and educational consequences of the medication. Some pertinent questions are posed.
D001288:Attention / Q000187:drug effects; D002648:Child; D002961:Civil Rights; D003913:Dextroamphetamine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005196:Family Therapy; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy* / Q000209:etiology; D007400:Interprofessional Relations; D008499:Medical Records; D008774:Methylphenidate / Q000627:therapeutic use*; D012931:Social Environment
D008774:Methylphenidate; D003913:Dextroamphetamine